Norfloxacin Lactate for Injection
Function and Efficacy
This product is a broad-spectrum antibacterial drug that works on both Gram-positive and Gram-negative bacteria. Bacteria are not easy to develop resistance to this product. There is no cross-resistance between similar drugs and antibiotics. This product has strong antibacterial activity against Gram-negative bacteria. In particular, bacteria of the Enterobacteriaceae family, such as Escherichia coli, Shigella, Klebsiella, Proteus, Enterobacter aerogenes, Serratia, Citrobacter, etc. are highly sensitive to this product. The minimum inhibitory concentration is generally less than 0.5μg/ml. Influenza bacillus is also highly sensitive to this product. Neisseria gonorrhoeae is sensitive to this product, and the minimum inhibitory concentration is 0.125μg/ml. This product also has an effect on Pseudomonas aeruginosa and other Pseudomonas, but a higher concentration is required, with a minimum inhibitory concentration of 4 to 32μg/ml; since the concentration of this product in urine exceeds the above concentration by several to more than ten times, it is still effective in treating Pseudomonas aeruginosa urinary tract infections. Among Gram-positive cocci, this product is more sensitive to Staphylococcus aureus and Staphylococcus epidermidis, and the lowest concentration for inhibiting 90% of bacteria is about 1-2μg/ml. The lowest concentration for inhibiting 90% of enterococci and pneumococci is about 4μg/ml and 16μg/ml.
Ingredients
Norfloxacin.
| Name | Description | Content | CAS NO. | Manufacturer |
|---|---|---|---|---|
| NorfloxacinIngredients |
This product is a broad-spectrum antibacterial drug that is effective against both Gram-positive and Gram-negative bacteria. Bacteria are not easy to develop resistance to this product. There is no cross-resistance between similar drugs and antibiotics. It has strong antibacterial activity against Gram-negative bacteria, especially bacteria of the Enterobacteriaceae family, such as Escherichia coli, Shigella, Klebsiella, Proteus, Enterobacter aerogenes, Serratia, Citrobacter, etc., which are highly sensitive, and the minimum inhibitory concentration is generally less than 0.5μg/ml. Influenzae is also highly sensitive to this product. Neisseria gonorrhoeae is sensitive to this product, with a minimum inhibitory concentration of 0.125μg/ml. It has an effect on Pseudomonas aeruginosa and other Pseudomonas, with a minimum inhibitory concentration of 4-32μg/ml. Among Gram-positive cocci, it is more sensitive to Staphylococcus aureus and Staphylococcus epidermidis, and the minimum concentration that inhibits 90% of bacteria is about 1-2μg/ml. The lowest concentrations for 90% inhibition of enterococci and pneumococci were approximately 4 μg/ml and 16 μg/ml respectively. More |
70458-96-7 | 34 |
Indication
It is suitable for respiratory tract, urinary tract and gastrointestinal tract infections caused by sensitive bacteria, such as acute bronchitis, acute exacerbation of chronic bronchitis, pneumonia, acute and chronic pyelonephritis, cystitis, typhoid fever, etc.
Usage and Dosage
Intravenous drip. For adults, take 0.2-0.4g at a time, diluted in 100-500ml of 5% glucose injection or normal saline, with a drip rate of 30-40 drops per minute. Twice a day, 7-14 days as a course of treatment. Or follow the doctor's advice.
Adverse Reactions
Not yet clear
Precautions
Not yet clear
Drug Interactions
Not yet clear
Storage
Keep tightly closed.
Packaging Specification
0.4g (calculated as C16H18FN3O3)